VBI Vaccines News - VBIV

Company Name	Stock Ticker Symbol	Market	Type
VBI Vaccines Inc	VBIV	NASDAQ	Common Stock

	Price Change	Change Percent	Stock Price	Last Traded
	0.0094	1.59%	0.5994	20:00:00

Open Price	Low Price	High Price	Close Price	Prev Close
0.59	0.5642	0.600001	0.5994	0.59

more quote information »

Recent News

Date	Time	Source	Heading
4/25/2024	8:52	IHNW	FeaturedCannabix's Breath Logix Alcohol Device Delivers Positive Impact to Private Monitoring Agency in Montana, USA
4/16/2024	08:00	BW	VBI Vaccines Reports Full Year 2023 Financial Results
4/11/2024	16:05	BW	VBI Vaccines Announces Closing of $2 Million Registered..
4/09/2024	14:45	BW	VBI Vaccines Announces $2 Million Registered Direct Offering..
4/03/2024	08:00	BW	VBI Vaccines Presents Encouraging Early Tumor Response Data..
4/02/2024	08:00	BW	VBI Vaccines Announces Expanded Strategic Partnership with..
2/14/2024	08:34	EDGAR2	Form 8-K - Current report
2/14/2024	07:00	BW	VBI Announces Agreement to Sell Manufacturing Capabilities,..
2/06/2024	16:23	EDGAR2	Form 8-K - Current report
1/23/2024	16:15	EDGAR2	Form 8-K - Current report
1/11/2024	16:15	EDGAR2	Form 8-K - Current report
12/26/2023	16:15	EDGAR2	Form 8-K - Current report
12/12/2023	16:15	EDGAR2	Form 8-K - Current report
11/29/2023	16:15	EDGAR2	Form 8-K - Current report
11/20/2023	08:00	EDGAR2	Form 8-K - Current report
11/20/2023	08:00	BW	VBI Vaccines Presents Additional Biomarker Data from Phase..
11/14/2023	16:07	EDGAR2	Form 8-K - Current report
11/14/2023	16:06	EDGAR2	Form 10-Q - Quarterly report [Sections 13 or 15(d)]
11/14/2023	16:05	BW	VBI Vaccines Reports Third Quarter 2023 Financial Results
11/03/2023	17:00	EDGAR2	Form 8-K - Current report
10/26/2023	08:00	EDGAR2	Form 8-K - Current report
10/26/2023	08:00	BW	VBI Vaccines Expands Proprietary Technology Platforms With..
9/27/2023	07:30	EDGAR2	Form 8-K - Current report
9/27/2023	07:30	BW	VBI Vaccines’ Pan-Coronavirus Vaccine Candidate, VBI-2901,..
9/07/2023	08:00	EDGAR2	Form 8-K - Current report
9/07/2023	08:00	BW	VBI Vaccines Announces Dosing of First Patients in Phase 2b..
9/06/2023	09:12	EDGAR2	Form 8-K - Current report
9/06/2023	08:00	BW	VBI Vaccines Partner Brii Biosciences Announces Topline..
8/14/2023	08:00	EDGAR2	Form 10-Q - Quarterly report [Sections 13 or 15(d)]
8/14/2023	08:00	EDGAR2	Form 8-K - Current report
8/14/2023	08:00	BW	VBI Vaccines Reports Second Quarter 2023 Financial Results
7/31/2023	17:00	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
7/31/2023	17:00	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
7/28/2023	18:30	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
7/28/2023	18:30	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
7/28/2023	18:30	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
7/28/2023	18:30	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
7/28/2023	18:30	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
7/28/2023	18:30	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
7/28/2023	18:30	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
7/28/2023	18:30	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
7/28/2023	18:30	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
7/28/2023	18:30	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
7/27/2023	16:05	EDGAR2	Form 8-K/A - Current report: [Amend]
7/24/2023	08:00	EDGAR2	Form 8-K - Current report
7/24/2023	08:00	BW	VBI Vaccines Announces Closing of Underwriters’ Partial..
7/20/2023	16:16	EDGAR2	Form SC 13G - Statement of acquisition of beneficial..
7/19/2023	08:00	EDGAR2	Form 8-K - Current report
7/19/2023	08:00	BW	VBI Vaccines Announces PreHevbri® is Now Available in the..
7/18/2023	09:00	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
7/11/2023	16:05	EDGAR2	Form 8-K - Current report